The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Vaccine for Non-infectious Meningitis Market Research Report 2025
Synopsis
Meningococcal conjugate vaccine is used to prevent infection caused by meningococcal bacteria.
The global Vaccine for Non-infectious Meningitis market was valued at US$ 1 million in 2023 and is anticipated to reach US$ 2 million by 2030, witnessing a CAGR of 12.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Vaccine for Non-infectious Meningitis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine for Non-infectious Meningitis.
Report Scope
The Vaccine for Non-infectious Meningitis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine for Non-infectious Meningitis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine for Non-infectious Meningitis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Serum Institute
Sanofi SA
Pfizer
Nuron Biotech
JN-International Medical
Segment by Type
Polysaccharide Vaccines
Conjugate Vaccines
Combination Vaccines
Men B Vaccines
Segment by Application
Meningitis
Septicemia
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vaccine for Non-infectious Meningitis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vaccine for Non-infectious Meningitis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Meningococcal conjugate vaccine is used to prevent infection caused by meningococcal bacteria.
The global Vaccine for Non-infectious Meningitis market was valued at US$ 1 million in 2023 and is anticipated to reach US$ 2 million by 2030, witnessing a CAGR of 12.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Vaccine for Non-infectious Meningitis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine for Non-infectious Meningitis.
Report Scope
The Vaccine for Non-infectious Meningitis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine for Non-infectious Meningitis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine for Non-infectious Meningitis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Serum Institute
Sanofi SA
Pfizer
Nuron Biotech
JN-International Medical
Segment by Type
Polysaccharide Vaccines
Conjugate Vaccines
Combination Vaccines
Men B Vaccines
Segment by Application
Meningitis
Septicemia
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vaccine for Non-infectious Meningitis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vaccine for Non-infectious Meningitis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Vaccine for Non-infectious Meningitis Market Overview
1.1 Product Overview and Scope of Vaccine for Non-infectious Meningitis
1.2 Vaccine for Non-infectious Meningitis Segment by Type
1.2.1 Global Vaccine for Non-infectious Meningitis Market Value Comparison by Type (2024-2030)
1.2.2 Polysaccharide Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Combination Vaccines
1.2.5 Men B Vaccines
1.3 Vaccine for Non-infectious Meningitis Segment by Application
1.3.1 Global Vaccine for Non-infectious Meningitis Market Value by Application: (2024-2030)
1.3.2 Meningitis
1.3.3 Septicemia
1.3.4 Others
1.4 Global Vaccine for Non-infectious Meningitis Market Size Estimates and Forecasts
1.4.1 Global Vaccine for Non-infectious Meningitis Revenue 2019-2030
1.4.2 Global Vaccine for Non-infectious Meningitis Sales 2019-2030
1.4.3 Global Vaccine for Non-infectious Meningitis Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Vaccine for Non-infectious Meningitis Market Competition by Manufacturers
2.1 Global Vaccine for Non-infectious Meningitis Sales Market Share by Manufacturers (2019-2024)
2.2 Global Vaccine for Non-infectious Meningitis Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Vaccine for Non-infectious Meningitis Average Price by Manufacturers (2019-2024)
2.4 Global Vaccine for Non-infectious Meningitis Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vaccine for Non-infectious Meningitis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccine for Non-infectious Meningitis, Product Type & Application
2.7 Vaccine for Non-infectious Meningitis Market Competitive Situation and Trends
2.7.1 Vaccine for Non-infectious Meningitis Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vaccine for Non-infectious Meningitis Players Market Share by Revenue
2.7.3 Global Vaccine for Non-infectious Meningitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vaccine for Non-infectious Meningitis Retrospective Market Scenario by Region
3.1 Global Vaccine for Non-infectious Meningitis Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Vaccine for Non-infectious Meningitis Global Vaccine for Non-infectious Meningitis Sales by Region: 2019-2030
3.2.1 Global Vaccine for Non-infectious Meningitis Sales by Region: 2019-2024
3.2.2 Global Vaccine for Non-infectious Meningitis Sales by Region: 2025-2030
3.3 Global Vaccine for Non-infectious Meningitis Global Vaccine for Non-infectious Meningitis Revenue by Region: 2019-2030
3.3.1 Global Vaccine for Non-infectious Meningitis Revenue by Region: 2019-2024
3.3.2 Global Vaccine for Non-infectious Meningitis Revenue by Region: 2025-2030
3.4 North America Vaccine for Non-infectious Meningitis Market Facts & Figures by Country
3.4.1 North America Vaccine for Non-infectious Meningitis Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Vaccine for Non-infectious Meningitis Sales by Country (2019-2030)
3.4.3 North America Vaccine for Non-infectious Meningitis Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vaccine for Non-infectious Meningitis Market Facts & Figures by Country
3.5.1 Europe Vaccine for Non-infectious Meningitis Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Vaccine for Non-infectious Meningitis Sales by Country (2019-2030)
3.5.3 Europe Vaccine for Non-infectious Meningitis Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccine for Non-infectious Meningitis Market Facts & Figures by Country
3.6.1 Asia Pacific Vaccine for Non-infectious Meningitis Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Vaccine for Non-infectious Meningitis Sales by Country (2019-2030)
3.6.3 Asia Pacific Vaccine for Non-infectious Meningitis Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vaccine for Non-infectious Meningitis Market Facts & Figures by Country
3.7.1 Latin America Vaccine for Non-infectious Meningitis Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Vaccine for Non-infectious Meningitis Sales by Country (2019-2030)
3.7.3 Latin America Vaccine for Non-infectious Meningitis Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccine for Non-infectious Meningitis Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccine for Non-infectious Meningitis Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Vaccine for Non-infectious Meningitis Sales by Country (2019-2030)
3.8.3 Middle East and Africa Vaccine for Non-infectious Meningitis Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Vaccine for Non-infectious Meningitis Sales by Type (2019-2030)
4.1.1 Global Vaccine for Non-infectious Meningitis Sales by Type (2019-2024)
4.1.2 Global Vaccine for Non-infectious Meningitis Sales by Type (2025-2030)
4.1.3 Global Vaccine for Non-infectious Meningitis Sales Market Share by Type (2019-2030)
4.2 Global Vaccine for Non-infectious Meningitis Revenue by Type (2019-2030)
4.2.1 Global Vaccine for Non-infectious Meningitis Revenue by Type (2019-2024)
4.2.2 Global Vaccine for Non-infectious Meningitis Revenue by Type (2025-2030)
4.2.3 Global Vaccine for Non-infectious Meningitis Revenue Market Share by Type (2019-2030)
4.3 Global Vaccine for Non-infectious Meningitis Price by Type (2019-2030)
5 Segment by Application
5.1 Global Vaccine for Non-infectious Meningitis Sales by Application (2019-2030)
5.1.1 Global Vaccine for Non-infectious Meningitis Sales by Application (2019-2024)
5.1.2 Global Vaccine for Non-infectious Meningitis Sales by Application (2025-2030)
5.1.3 Global Vaccine for Non-infectious Meningitis Sales Market Share by Application (2019-2030)
5.2 Global Vaccine for Non-infectious Meningitis Revenue by Application (2019-2030)
5.2.1 Global Vaccine for Non-infectious Meningitis Revenue by Application (2019-2024)
5.2.2 Global Vaccine for Non-infectious Meningitis Revenue by Application (2025-2030)
5.2.3 Global Vaccine for Non-infectious Meningitis Revenue Market Share by Application (2019-2030)
5.3 Global Vaccine for Non-infectious Meningitis Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Serum Institute
6.1.1 Serum Institute Corporation Information
6.1.2 Serum Institute Description and Business Overview
6.1.3 Serum Institute Vaccine for Non-infectious Meningitis Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Serum Institute Vaccine for Non-infectious Meningitis Product Portfolio
6.1.5 Serum Institute Recent Developments/Updates
6.2 Sanofi SA
6.2.1 Sanofi SA Corporation Information
6.2.2 Sanofi SA Description and Business Overview
6.2.3 Sanofi SA Vaccine for Non-infectious Meningitis Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi SA Vaccine for Non-infectious Meningitis Product Portfolio
6.2.5 Sanofi SA Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Vaccine for Non-infectious Meningitis Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Vaccine for Non-infectious Meningitis Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Nuron Biotech
6.4.1 Nuron Biotech Corporation Information
6.4.2 Nuron Biotech Description and Business Overview
6.4.3 Nuron Biotech Vaccine for Non-infectious Meningitis Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nuron Biotech Vaccine for Non-infectious Meningitis Product Portfolio
6.4.5 Nuron Biotech Recent Developments/Updates
6.5 JN-International Medical
6.5.1 JN-International Medical Corporation Information
6.5.2 JN-International Medical Description and Business Overview
6.5.3 JN-International Medical Vaccine for Non-infectious Meningitis Sales, Revenue and Gross Margin (2019-2024)
6.5.4 JN-International Medical Vaccine for Non-infectious Meningitis Product Portfolio
6.5.5 JN-International Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccine for Non-infectious Meningitis Industry Chain Analysis
7.2 Vaccine for Non-infectious Meningitis Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccine for Non-infectious Meningitis Production Mode & Process
7.4 Vaccine for Non-infectious Meningitis Sales and Marketing
7.4.1 Vaccine for Non-infectious Meningitis Sales Channels
7.4.2 Vaccine for Non-infectious Meningitis Distributors
7.5 Vaccine for Non-infectious Meningitis Customers
8 Vaccine for Non-infectious Meningitis Market Dynamics
8.1 Vaccine for Non-infectious Meningitis Industry Trends
8.2 Vaccine for Non-infectious Meningitis Market Drivers
8.3 Vaccine for Non-infectious Meningitis Market Challenges
8.4 Vaccine for Non-infectious Meningitis Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Vaccine for Non-infectious Meningitis Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Vaccine for Non-infectious Meningitis Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Vaccine for Non-infectious Meningitis Market Competitive Situation by Manufacturers in 2023
Table 4. Global Vaccine for Non-infectious Meningitis Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Vaccine for Non-infectious Meningitis Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Vaccine for Non-infectious Meningitis Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Vaccine for Non-infectious Meningitis Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Vaccine for Non-infectious Meningitis Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Vaccine for Non-infectious Meningitis, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Vaccine for Non-infectious Meningitis, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vaccine for Non-infectious Meningitis, Product Type & Application
Table 12. Global Key Manufacturers of Vaccine for Non-infectious Meningitis, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vaccine for Non-infectious Meningitis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine for Non-infectious Meningitis as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vaccine for Non-infectious Meningitis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Vaccine for Non-infectious Meningitis Sales by Region (2019-2024) & (K Units)
Table 18. Global Vaccine for Non-infectious Meningitis Sales Market Share by Region (2019-2024)
Table 19. Global Vaccine for Non-infectious Meningitis Sales by Region (2025-2030) & (K Units)
Table 20. Global Vaccine for Non-infectious Meningitis Sales Market Share by Region (2025-2030)
Table 21. Global Vaccine for Non-infectious Meningitis Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Region (2019-2024)
Table 23. Global Vaccine for Non-infectious Meningitis Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Region (2025-2030)
Table 25. North America Vaccine for Non-infectious Meningitis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Vaccine for Non-infectious Meningitis Sales by Country (2019-2024) & (K Units)
Table 27. North America Vaccine for Non-infectious Meningitis Sales by Country (2025-2030) & (K Units)
Table 28. North America Vaccine for Non-infectious Meningitis Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Vaccine for Non-infectious Meningitis Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Vaccine for Non-infectious Meningitis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Vaccine for Non-infectious Meningitis Sales by Country (2019-2024) & (K Units)
Table 32. Europe Vaccine for Non-infectious Meningitis Sales by Country (2025-2030) & (K Units)
Table 33. Europe Vaccine for Non-infectious Meningitis Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Vaccine for Non-infectious Meningitis Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Vaccine for Non-infectious Meningitis Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Vaccine for Non-infectious Meningitis Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Vaccine for Non-infectious Meningitis Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Vaccine for Non-infectious Meningitis Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Vaccine for Non-infectious Meningitis Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Vaccine for Non-infectious Meningitis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Vaccine for Non-infectious Meningitis Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Vaccine for Non-infectious Meningitis Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Vaccine for Non-infectious Meningitis Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Vaccine for Non-infectious Meningitis Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Vaccine for Non-infectious Meningitis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Vaccine for Non-infectious Meningitis Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Vaccine for Non-infectious Meningitis Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Vaccine for Non-infectious Meningitis Sales (K Units) by Type (2019-2024)
Table 51. Global Vaccine for Non-infectious Meningitis Sales (K Units) by Type (2025-2030)
Table 52. Global Vaccine for Non-infectious Meningitis Sales Market Share by Type (2019-2024)
Table 53. Global Vaccine for Non-infectious Meningitis Sales Market Share by Type (2025-2030)
Table 54. Global Vaccine for Non-infectious Meningitis Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Vaccine for Non-infectious Meningitis Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Type (2019-2024)
Table 57. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Type (2025-2030)
Table 58. Global Vaccine for Non-infectious Meningitis Price (USD/Unit) by Type (2019-2024)
Table 59. Global Vaccine for Non-infectious Meningitis Price (USD/Unit) by Type (2025-2030)
Table 60. Global Vaccine for Non-infectious Meningitis Sales (K Units) by Application (2019-2024)
Table 61. Global Vaccine for Non-infectious Meningitis Sales (K Units) by Application (2025-2030)
Table 62. Global Vaccine for Non-infectious Meningitis Sales Market Share by Application (2019-2024)
Table 63. Global Vaccine for Non-infectious Meningitis Sales Market Share by Application (2025-2030)
Table 64. Global Vaccine for Non-infectious Meningitis Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Vaccine for Non-infectious Meningitis Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Application (2019-2024)
Table 67. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Application (2025-2030)
Table 68. Global Vaccine for Non-infectious Meningitis Price (USD/Unit) by Application (2019-2024)
Table 69. Global Vaccine for Non-infectious Meningitis Price (USD/Unit) by Application (2025-2030)
Table 70. Serum Institute Corporation Information
Table 71. Serum Institute Description and Business Overview
Table 72. Serum Institute Vaccine for Non-infectious Meningitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Serum Institute Vaccine for Non-infectious Meningitis Product
Table 74. Serum Institute Recent Developments/Updates
Table 75. Sanofi SA Corporation Information
Table 76. Sanofi SA Description and Business Overview
Table 77. Sanofi SA Vaccine for Non-infectious Meningitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Sanofi SA Vaccine for Non-infectious Meningitis Product
Table 79. Sanofi SA Recent Developments/Updates
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Vaccine for Non-infectious Meningitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Pfizer Vaccine for Non-infectious Meningitis Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Nuron Biotech Corporation Information
Table 86. Nuron Biotech Description and Business Overview
Table 87. Nuron Biotech Vaccine for Non-infectious Meningitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Nuron Biotech Vaccine for Non-infectious Meningitis Product
Table 89. Nuron Biotech Recent Developments/Updates
Table 90. JN-International Medical Corporation Information
Table 91. JN-International Medical Description and Business Overview
Table 92. JN-International Medical Vaccine for Non-infectious Meningitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. JN-International Medical Vaccine for Non-infectious Meningitis Product
Table 94. JN-International Medical Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Vaccine for Non-infectious Meningitis Distributors List
Table 98. Vaccine for Non-infectious Meningitis Customers List
Table 99. Vaccine for Non-infectious Meningitis Market Trends
Table 100. Vaccine for Non-infectious Meningitis Market Drivers
Table 101. Vaccine for Non-infectious Meningitis Market Challenges
Table 102. Vaccine for Non-infectious Meningitis Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Vaccine for Non-infectious Meningitis
Figure 2. Global Vaccine for Non-infectious Meningitis Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Vaccine for Non-infectious Meningitis Market Share by Type in 2023 & 2030
Figure 4. Polysaccharide Vaccines Product Picture
Figure 5. Conjugate Vaccines Product Picture
Figure 6. Combination Vaccines Product Picture
Figure 7. Men B Vaccines Product Picture
Figure 8. Global Vaccine for Non-infectious Meningitis Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Vaccine for Non-infectious Meningitis Market Share by Application in 2023 & 2030
Figure 10. Meningitis
Figure 11. Septicemia
Figure 12. Others
Figure 13. Global Vaccine for Non-infectious Meningitis Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Vaccine for Non-infectious Meningitis Market Size (2019-2030) & (US$ Million)
Figure 15. Global Vaccine for Non-infectious Meningitis Sales (2019-2030) & (K Units)
Figure 16. Global Vaccine for Non-infectious Meningitis Average Price (USD/Unit) & (2019-2030)
Figure 17. Vaccine for Non-infectious Meningitis Report Years Considered
Figure 18. Vaccine for Non-infectious Meningitis Sales Share by Manufacturers in 2023
Figure 19. Global Vaccine for Non-infectious Meningitis Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Vaccine for Non-infectious Meningitis Players: Market Share by Revenue in 2023
Figure 21. Vaccine for Non-infectious Meningitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Vaccine for Non-infectious Meningitis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Vaccine for Non-infectious Meningitis Sales Market Share by Country (2019-2030)
Figure 24. North America Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Vaccine for Non-infectious Meningitis Sales Market Share by Country (2019-2030)
Figure 28. Europe Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2019-2030)
Figure 29. Germany Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Vaccine for Non-infectious Meningitis Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Vaccine for Non-infectious Meningitis Revenue Market Share by Region (2019-2030)
Figure 36. China Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Vaccine for Non-infectious Meningitis Sales Market Share by Country (2019-2030)
Figure 47. Latin America Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Vaccine for Non-infectious Meningitis Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Vaccine for Non-infectious Meningitis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Vaccine for Non-infectious Meningitis by Type (2019-2030)
Figure 57. Global Revenue Market Share of Vaccine for Non-infectious Meningitis by Type (2019-2030)
Figure 58. Global Vaccine for Non-infectious Meningitis Price (USD/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Vaccine for Non-infectious Meningitis by Application (2019-2030)
Figure 60. Global Revenue Market Share of Vaccine for Non-infectious Meningitis by Application (2019-2030)
Figure 61. Global Vaccine for Non-infectious Meningitis Price (USD/Unit) by Application (2019-2030)
Figure 62. Vaccine for Non-infectious Meningitis Value Chain
Figure 63. Vaccine for Non-infectious Meningitis Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
